Tuesday September 17, 2019
Home India Delhi HC Just...

Delhi HC Justice Rohini dismisses allegations of favouritism in Judicial recruitment 2015

0
//
photo credit: www.livemint.com

By NewsGram Staff Writer

In a letter to law minister Sadananda Gowda, Justice Rohini put an end to the accusations surrounding the recruitment of judges’ children in the Delhi subordinate judiciary examination in May, Delhi High Court Chief Justice G Rohini has justified the selections and said the entire process was transparent and as per norms.

 

photo credit: www.livelaw.in
photo credit: www.livelaw.in

Justice Rohini said two of the 15 qualified candidates in the Delhi judicial service exam were children of two sitting judges of the HC but “they have qualified on their own and the allegations of favouritism and nepotism are unfounded and unwarranted”.

Considering the matter to be closed for any further investigation, the chief justice wrote that there was no ground for cancelling the selection process. “There is also no rule for revaluation of answer-sheets,” she said. The matter is under the scrutiny of the Supreme Court which had earlier sought response from the Delhi HC based on a PIL.

The Delhi HC HAD found that only 15 candidates got the required grades to be invited for an interview. All 15 were selected, including two children of two sitting judges of the HC.

Immediately after the results were announced, complaints were filed with the law ministry with some alleging that deserving candidates were overlooked despite the fact that many of them had topped the judicial services exams of 11 states and at least 64 of them were serving as judicial officers in different states.

Law minister Gowda forwarded these complaints to the chief justice of Delhi HC on June 18 with a letter requesting a probe into allegations of favouritism where kin of two sitting Delhi HC judges were among 15 successful candidates. He also brought to the notice of the CJ the allegation that judges were part of the examination process.

Justice Rohini, in her response, said, “It may at the outset be stated that the allegations of corruption, favouritism and nepotism made in the grievances that were received by your office and enclosed to your letter dated 18th June are absolutely unfounded and baseless.”

She said the “allegation that the answer-sheets were evaluated by sitting judges whose sons/daughters/relatives took the exam is factually incorrect. The evaluation of answer scripts was not done by any of the sitting judges of this court”.

Justice Rohini pointed out that “children of several other judges, both of this court and subordinate courts, as well as the children of retired judicial officers were among the 659 candidates who appeared for the main exam, but except for the above two candidates, none qualified”.

Talking about the transparency maintained in the evaluation process, Justice Rohini said the HC had permitted all those candidates who had applied under RTI Act to inspect their answer-sheets while ruling out any revaluation. She said the Delhi HC had already notified the next judicial service examination and the schedule for the recruitment process had been fixed.

(With inputs from TOI)

Next Story

Delhi High Court Directs Private Clinic to Continue with the Stem Cell Treatment

The clinic, which is administering the medicine, cannot function under the new rules until the licence is duly obtained

0
Order
Delhi High Court. Source- Wikimedia

In an interim relief, the Delhi High Court has directed a private clinic to continue with the stem cell treatment being provided to the patients till its further orders.

The court’s interim direction came while hearing various petitions challenging the Centre’s decision to put stem cell therapy in the category of new drugs.

The petitioners were being provided stem cell treatment in Nutech Mediworld Clinic in Green Park here.

A Division Bench of justices Anu Malhotra and Talwant Singh said that all details of treatment being provided to the petitioners by the clinic be placed on record with an affidavit.

Representational image.

The court has sought the response of Centre and Indian Council of Medical Research to file reply on the petition and listed the matter for September 4 for further hearing.

The court has directed authorities concerned to examine whether the products being administered to the petitioners, prima facie, fall within the scope of the expression ‘new drugs’ as defined under Rule 2(1) (w) of New Drugs and Clinical Trial Rules, 2019 and communicate the view to the petitioners and the said clinic.

Also Read- LG CNS, Microsoft to Develop Cloud-based Enterprise Solutions

On account of the Centre’s fresh notification on ‘New Drugs and Clinical Rule 2019’, some medications used for the treatment would fall under the definition of ‘new drug’ and require approval from the authority concerned.

The clinic, which is administering the medicine, cannot function under the new rules until the licence is duly obtained. (IANS)